February 4, 2008 - Misonix Inc., a developer of minimally invasive ultrasonic medical device technology for the ablation of cancer and other chronic health conditions, today said that it has entered into a distribution agreement with Aesculap Inc., a subsidiary of B. Braun, for the domestic distribution of the Misonix BoneScalpel, a new Ultrasonic Osteotome (or bone cutting device) for use in orthopedic and neurological applications related to the spine and cranium.
For more information: www.misonix.com
March 02, 2026 
